DEA proposes long-awaited rule for telehealth controlled substance prescriptions

Healthcare DIVE January 16, 2025
Emily Olsen

However, telehealth advocates raised concerns about restrictions included in the rule, with one group asking President-elect Donald Trump to withdraw the proposal.

Dive Brief:

• The Drug Enforcement Administration released a long-awaited regulation on Wednesday that would create a process for prescribing controlled substances via telehealth, just days before President Joe Biden’s term ends.
• The proposed rule would create special registrations authorizing providers and telehealth companies to prescribe Schedule II to V drugs, like Adderall or Xanax, without first conducting an in-person evaluation. The agency also finalized a regulation that allows registered practitioners to virtually dispense buprenorphine, a medication for opioid use disorder.
• Although telehealth proponents have urged regulators to enshrine pandemic-era virtual prescribing flexibilities, some industry groups said...

Today's Sponsors

Today's Sponsor